Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $296.27 (market cap $8.04B), while Direxion Daily Semiconductor Bear 3X Shares trades at $48.04. Which is the better fit depends on your goals.
| BIO | SOXS | |
|---|---|---|
Market Cap | $8.04B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $339.75 | $1.61K |
52-Week Low | $241.71 | $32.50 |
Enterprise Value | $7.85B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.
Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $46.65, up 14.34% on the day amid semiconductor sector volatility. Technical indicators show a neutral overall signal with bearish moving averages. The ETF is scheduled for a 1:10 stock split on July 15, 2026, and declared a $0.04 dividend for H1-2026. Recent news highlights the ETF's role in betting against the AI-driven semiconductor rally, with SOXS down significantly over six months as chip stocks surge.
The outlook for SOXS remains highly speculative, offering leveraged inverse exposure to semiconductors. Key opportunities include hedging against a potential semiconductor downturn, but risks are extreme due to the ETF's bearish structure in a strong bull market. Volatility decay and the sector's momentum pose substantial threats to long-term holders, making it suitable only for tactical, short-term trading.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
